NextPoint is presenting 4 posters at #AACR2025! We're showcasing preclinical data on our B7-H7-targeted ADC and TCE programs. B7-H7 is upregulated across multiple cancer types with limited normal tissue expression— an ideal precision oncology target. bit.ly/4iWjmSN